Pfizer's vitiligo pill succeeds; eczema drug lacks differentiation
Pfizer advances in two skin conditions: a pivotal vitiligo win for Litfulo and a mid-stage eczema result that analysts call competitive but not differentiated.
Clinical AI, drug discovery, devices, and regulatory approvals.
Pfizer advances in two skin conditions: a pivotal vitiligo win for Litfulo and a mid-stage eczema result that analysts call competitive but not differentiated.
The settlement adds to a growing list of Medicare Advantage insurers accused of inflating risk scores to boost federal payments.
The Series A round, led by Canvas Ventures, will support the company's conversational agentic platform.
A phase II trial found that 4 Gy of radiation, given in one or two fractions, produced durable pain relief in most myeloma patients while preserving bone marrow.
A CDC-backed study using mystery patients found that most healthcare facilities missed target times for masking and isolating potential avian flu cases.
A conversion failure, not a consent failure, explains why more than 300,000 patient records are missing from the All of Us research program.
Blue Shield of California says it will adapt Medicare's ACCESS chronic-care payment model for commercial plans starting in 2027.
A multinational study found that patients with lean metabolic dysfunction-associated steatotic liver disease had similar risks of death and clinical events as those with overweight or obese disease, with fibrosis severity being the key predictor.
Three Republican-led states ask the Supreme Court to let them enforce abortion bans against out-of-state providers protected by shield laws.
A new survey finds most patients want human oversight of AI health tools, and fewer than a third use AI for tasks like finding providers or diet planning.
The 988 Suicide & Crisis Lifeline has brought back the 'Press 3' option for LGBTQ+ youth after it was cut more than a year ago.
The platform's decision highlights the vulnerability of high-profile medical crowdfunding campaigns to factual disputes.
The National Institutes of Health is launching a redesigned website that groups information into eight topic-based hubs, aiming to replace a sprawling network of more than 700 separate sites.
A new Annenberg survey finds public belief in a vaccine-autism link remains low but has slipped since 2021, while Health Secretary Kennedy's unfavorable ratings deepen amid measles outbreaks.
A county-level study links higher medical debt burdens to more late-stage cancer diagnoses, with the strongest effect seen in lung cancer.
The Debunked podcast hosts discuss how the CMS ACCESS Model could address shortcomings of traditional value-based care arrangements.
A BioPharma Dive roundup covers Lilly's Foghorn exit, Wave's FDA plans, Teva-Samsung Bioepis expansion, and Varda's $251M raise.
Applying data, behavioral insights, and experimentation to organizational culture could improve patient outcomes, clinician wellbeing, and performance.